Tracing the international arrivals of SARS-CoV-2 Omicron variants after Aotearoa New Zealand reopened its border

dc.citation.issue1
dc.citation.volume13
dc.contributor.authorDouglas J
dc.contributor.authorWinter D
dc.contributor.authorMcNeill A
dc.contributor.authorCarr S
dc.contributor.authorBunce M
dc.contributor.authorFrench N
dc.contributor.authorHadfield J
dc.contributor.authorde Ligt J
dc.contributor.authorWelch D
dc.contributor.authorGeoghegan JL
dc.coverage.spatialEngland
dc.date.accessioned2024-01-25T00:27:08Z
dc.date.accessioned2024-07-25T06:53:34Z
dc.date.available2022-10-29
dc.date.available2024-01-25T00:27:08Z
dc.date.available2024-07-25T06:53:34Z
dc.date.issued2022-10-29
dc.description.abstractIn the second quarter of 2022, there was a global surge of emergent SARS-CoV-2 lineages that had a distinct growth advantage over then-dominant Omicron BA.1 and BA.2 lineages. By generating 10,403 Omicron genomes, we show that Aotearoa New Zealand observed an influx of these immune-evasive variants (BA.2.12.1, BA.4, and BA.5) through the border. This is explained by the return to significant levels of international travel following the border's reopening in March 2022. We estimate one Omicron transmission event from the border to the community for every ~5,000 passenger arrivals at the current levels of travel and restriction. Although most of these introductions did not instigate any detected onward transmission, a small minority triggered large outbreaks. Genomic surveillance at the border provides a lens on the rate at which new variants might gain a foothold and trigger new waves of infection.
dc.description.confidentialfalse
dc.format.pagination6484-
dc.identifier.author-urlhttps://www.ncbi.nlm.nih.gov/pubmed/36309507
dc.identifier.citationDouglas J, Winter D, McNeill A, Carr S, Bunce M, French N, Hadfield J, de Ligt J, Welch D, Geoghegan JL. (2022). Tracing the international arrivals of SARS-CoV-2 Omicron variants after Aotearoa New Zealand reopened its border.. Nat Commun. 13. 1. (pp. 6484-).
dc.identifier.doi10.1038/s41467-022-34186-9
dc.identifier.eissn2041-1723
dc.identifier.elements-typejournal-article
dc.identifier.issn2041-1723
dc.identifier.number6484
dc.identifier.pii10.1038/s41467-022-34186-9
dc.identifier.urihttps://mro.massey.ac.nz/handle/10179/71110
dc.languageeng
dc.publisherSpringer Nature Limited
dc.publisher.urihttps://www.nature.com/articles/s41467-022-34186-9
dc.relation.isPartOfNat Commun
dc.rights(c) 2022 The Author/s
dc.rightsCC BY 4.0
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.subjectHumans
dc.subjectNew Zealand
dc.subjectSARS-CoV-2
dc.subjectCOVID-19
dc.subjectDisease Outbreaks
dc.titleTracing the international arrivals of SARS-CoV-2 Omicron variants after Aotearoa New Zealand reopened its border
dc.typeJournal article
pubs.elements-id457881
pubs.organisational-groupOther
Files
Original bundle
Now showing 1 - 5 of 10
Loading...
Thumbnail Image
Name:
Evidence 1
Size:
329.92 KB
Format:
Adobe Portable Document Format
Description:
Loading...
Thumbnail Image
Name:
Evidence 2
Size:
329.92 KB
Format:
Adobe Portable Document Format
Description:
Loading...
Thumbnail Image
Name:
Evidence 3
Size:
329.91 KB
Format:
Unknown data format
Description:
Loading...
Thumbnail Image
Name:
Evidence 4
Size:
329.92 KB
Format:
Adobe Portable Document Format
Description:
Loading...
Thumbnail Image
Name:
Evidence 5
Size:
329.92 KB
Format:
Adobe Portable Document Format
Description:
Collections